Answers are grounded in this paper and cite their sources.
Aim: Neutrophil gelatinase-associated lipocalin (NGAL) performs important functions in the body.It has the potential to act as a diagnostic and prognostic biomarker for various diseases.Background: The role of NGAL has been well explored in acute and chronic kidney diseases (CKDs).It is considered a maker for acute kidney injury (AKI).Its role in other diseases has also been increasingly reported.Results: Neutrophil gelatinase-associated lipocalin takes part in the pathogenesis of several diseases, besides renal diseases, like cardiovascular diseases, inflammatory disorders, cancer, diabetes, etc. by a variety of mechanisms.Its levels have been correlated with the severity in most of the diseases.Conclusion: Neutrophil gelatinase-associated lipocalin can act as a biomarker in different diseases though, its potential is yet to be explored to the maximum.Clinical significance: Estimating the levels of NGAL in body fluids will help in making an early diagnosis, assessing the severity of the disease, establishing a prognosis, and improving the overall management of different diseases.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: